BioMarin Rolls Up Sleeves To Prepare For Roctavian’s EU Debut

Positive CHMP Opinion Makes Approval Likely

 
• By Alaric DeArment
  
BioMarin announced a positive CHMP opinion for Roctavian, its gene therapy for hemophilia A • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Gene Therapies

More from Advanced Therapies